349 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $49.22 $125.51B Downtrend
Article Searches
Stocks To Watch: Any Privacy For Tesla? https://seekingalpha.com/article/4197968-stocks-watch-privacy-tesla?source=feed Aug 11, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus http://www.zacks.com/stock/news/317383/pharma-stock-roundup-nvo-q2-earnings-jnj-agn-azns-pipeline-updates-in-focus?cid=CS-ZC-FT-317383 Aug 10, 2018 - Novo Nordisk (NVO) reports strong Q2 results. J&J (JNJ) seeks approval for new dosing regimen of multiple myeloma drug. Allergan (AGN) exercises option to buy Editas' lead ocular candidate.
Stocks making the biggest moves premarket: KORS, CVS, DIS, PZZA & more https://www.cnbc.com/2018/08/08/stocks-making-the-biggest-moves-premarket-kors-cvs-dis-pzza--more.html Aug 08, 2018 - Names on the move ahead of the open.
Lilly (LLY) Issues Update on Diabetes Drug Trulicity Label http://www.zacks.com/stock/news/312546/lilly-lly-issues-update-on-diabetes-drug-trulicity-label?cid=CS-ZC-FT-312546 Jul 20, 2018 - Lilly (LLY) updates Trulicity's label to include data from a new study on patients with type II diabetes suffering from moderate to severe chronic kidney disease.
LLY vs. NVO: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/312230/lly-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC-FT-312230 Jul 19, 2018 - LLY vs. NVO: Which Stock Is the Better Value Option?
LLY vs. NVO: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/312246/lly-vs-nvo-which-stock-is-the-better-value-option?cid=CS-ZC--312246 Jul 19, 2018 - LLY vs. NVO: Which Stock Is the Better Value Option?
Air Pollution In Emerging Markets To Benefit Novo Nordisk https://seekingalpha.com/article/4186009-air-pollution-emerging-markets-benefit-novo-nordisk?source=feed_sector_healthcare Jul 09, 2018 - A recent study shows that the level of air pollution in an area increases the risks of the inhabitants of that area to contract type-2 diabetes. Emerging markets often do not have the pollution contro
Novo Nordisk: Obesity Crisis Continues To Get Worse - Buy The Stock Today https://seekingalpha.com/article/4179020-novo-nordisk-obesity-crisis-continues-get-worse-buy-stock-today?source=feed_sector_healthcare Jun 03, 2018 - By 2045, almost a quarter of the world's population is expected to be obese compared to 14% today. This is expected to increase the prevalence of type-2 diabetes in the general population. Novo Nordis
Stocks making the biggest moves premarket: DKS, TGT, CRM, HPQ, NVO, KORS & more https://www.cnbc.com/2018/05/30/stocks-making-the-biggest-moves-premarket-dks-tgt-crm-hpq-nvo-kors-more.html May 30, 2018 - Names on the move ahead of the open.
Novo Nordisk's Oral Ozempic Positive in Diabetes Study http://www.zacks.com/stock/news/305565/novo-nordisks-oral-ozempic-positive-in-diabetes-study?cid=CS-ZC-FT-305565 May 30, 2018 - Novo Nordisk's (NVO) oral formulation of Ozempic acts better in lowering blood sugar levels in adults with type II diabetes than Eli Lilly's Jardiance, in the second phase IIIa study, PIONEER 2.

Pages: 123456...35

Page 1>

Related Companies

Name Exchange Price Mkt Cap
SNY Sanofi NYSE $50.34 $126.04B
TIG TiGenix NASDAQ $24 $124.78B
CELG Celgene Corporation NASDAQ $143.91 $112.59B
ABBV AbbVie Inc. NYSE $87.48 $139.45B
BMY Bristol-Myers Squibb Company NYSE $63.36 $103.91B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Novo Nordisk A/S